How to maximize use of technology under master protocols for complex oncology studies
Understand the challenges associated with basket and umbrella trial design within oncology studies and learn how to innovate your study design strategy to increase trial flexibility and agility
Add bookmark
The underlying goal of using master protocols is to increase efficiency and expedite drug development for critical unmet needs. With the US Food and Drug Administration encouraging creativity in trial designs through newly introduced regulatory guidance, it is important for all stakeholders (sponsors, clinical research organizations and vendors) to adapt their processes and ensure medicines are delivered to patients, faster.
In this white paper, 4G Clinical discusses the different types of master protocol studies, addresses the complexities that come with these types of study design, and explores how technology – specifically modern randomization and trial supply management (RTSM) solutions – are critical to run flexible, robust and quality-driven trials.
Share best practice, ideas, and solutions to our global community of more than 125,000 senior pharmaceutical and biotech professionals. View our latest Media Kit to learn more about our audience and review our content calendar. Download NowInterested in presenting your own Case Study?
Download this white paper to learn:
- What are master protocol trials and what are the related global agency regulations.
- Which study type best fits with your clinical trial design.
- How to solve the key challenges of executing master protocol studies.
- Why a modern, configurable RTSM system can help overcome unique processes and quality challenges.
Download your copy now to innovate your clinical trial design.
